Neha Patil

AB PINACA

Updated on
Share on FacebookTweet on TwitterShare on LinkedIn
CAS Number  1445752-09-9
ChemSpider  28537615
3D model (Jmol)  Interactive image
PubChem CID  71301472
Formula  C18H26N4O2
Molar mass  330.43 g/mol
AB-PINACA httpsuploadwikimediaorgwikipediacommonsthu
Legal status  CA: Schedule II DE: Anlage II (Prohibited) US: Schedule I

AB-PINACA is a compound that was first identified as a component of synthetic cannabis products in Japan in 2012.

Contents

It was originally developed by Pfizer in 2009 as an analgesic medication.

AB-PINACA acts as a potent agonist for the CB1 receptor (Ki = 2.87 nM, EC50 = 1.2 nM) and CB2 receptor (Ki = 0.88 nM, EC50 = 2.5 nM) and fully substitutes for Δ9-THC in rat discrimination studies, while being 1.5x more potent.

Side effects

There have been a number of reported cases of deaths and hospitalizations in relation to this synthetic cannabinoid.

Legality

AB-PINACA is an Anlage II controlled substance in Germany as of November 2014.

AB-PINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.

It's a Schedule I controlled substance in the USA.

As of October 2015 AB-PINACA is a controlled substance in China.

References

AB-PINACA Wikipedia


Similar Topics
Kuttram Kadithal
Anca Barna
Michaela Meijer
Topics